Igor Morozov, Natasha N Gaudreault, Jessie D Trujillo, Sabarish V Indran, Konner Cool, Taeyong Kwon, David A Meekins, Velmurugan Balaraman, Bianca Libanori Artiaga, Daniel W Madden, Chester McDowell, Bradley Njaa, Jamie Retallick, Nicole Hainer, Jason Millership, William C Wilson, George Tkalcevic, Hanne Vander Horst, Yulia Burakova, Vickie King, Kendra Hutchinson, John M Hardham, Denise J Schwahn, Mahesh Kumar, Juergen A Richt. Preliminary Study on the Efficacy of a Recombinant, Subunit SARS-CoV-2 Animal Vaccine against Virulent SARS-CoV-2 Challenge in Cats.Vaccines. 2023, 11 (12):
Adidja Amani, Ekra Kouadio Daniel, Brou Gbotto, Kossia Yao, Aka Lépri Nicaise, Epa Kouakou, Kouadio Sie Kabran, Gervais Gahongano, Abdoul Gadiry Fadiga, Abdou Aziz Gbaya, Oniovo Efe-Aluta, Franck Mboussou, Imran Mirza, Benjamin Schreiber. First Field Test of the Novel Integration Mapping Tool for COVID-19 Vaccination Integration into National Immunization Programs and Primary Healthcare-A Case Study from Côte d'Ivoire.Vaccines. 2023, 11 (12):
Rodolfo Villena, Marco Aurelio Safadi, Ángela Gentile, Mónica Pujadas, Verónica De la Maza, Sergio George, Juan Pablo Torres. Epidemiology of Meningococcal Disease in Four South American Countries and Rationale of Vaccination in Adolescents from the Region: Position Paper of the Latin American Society of Pediatric Infectious Diseases (SLIPE).Vaccines. 2023, 11 (12):
Wojciech Malchrzak, Mateusz Babicki, Dagmara Pokorna-Kałwak, Agnieszka Mastalerz-Migas. The Influence of Introducing Free Vaccination against on the Uptake of Recommended Vaccination in Poland.Vaccines. 2023, 11 (12):
Amar Raj, Awnish Kumar Singh, Abram L Wagner, Matthew L Boulton. Mapping the Cognitive Biases Related to Vaccination: A Scoping Review of the Literature.Vaccines. 2023, 11 (12):
Pedro Plans-Rubió. Effectiveness of Adapted COVID-19 Vaccines and Ability to Establish Herd Immunity against Omicron BA.1 and BA4-5 Variants of SARS-CoV-2.Vaccines. 2023, 11 (12):
Alejo Erice, Lola Prieto, Cristina Caballero. Long-Term Analyses of SARS-CoV-2 Humoral and T Cell Responses and Breakthrough SARS-CoV-2 Infections after Two Doses of BNT162b2 Followed by mRNA-1273 and Bivalent Omicron-Adapted BNT162b2 Vaccines: A Prospective Study over 2 Years in Non-Immunocompromised Individuals.Vaccines. 2023, 11 (12):
Xin Wei Liew, Zer Han Malcolm Tang, Yan Qing Cherie Ong, Kay Choong See. Hearing Loss after COVID-19 and Non-COVID-19 Vaccination: A Systematic Review.Vaccines. 2023, 11 (12):
Michael Schoefbaenker, Rieke Neddermeyer, Theresa Guenther, Marlin M Mueller, Marie-Luise Romberg, Nica Classen, Marc T Hennies, Eike R Hrincius, Stephan Ludwig, Joachim E Kuehn, Eva U Lorentzen. Surrogate Virus Neutralisation Test Based on Nanoluciferase-Tagged Antigens to Quantify Inhibitory Antibodies against SARS-CoV-2 and Characterise Omicron-Specific Reactivity in a Vaccination Cohort.Vaccines. 2023, 11 (12):
Alessandra Fallucca, Patrizia Ferro, Luca Mazzeo, Luigi Zagra, Elena Cocciola, Roberta Oliveri, Antonino Tuttolomondo, Alida Benfante, Salvatore Battaglia, Nicola Scichilone, Nicola Veronese, Marco Affronti, Mario Barbagallo, Alessandra Casuccio, Francesco Vitale, Vincenzo Restivo, The Aoup Inpatient Vaccination Team. Impact of Actively Offering Influenza Vaccination to Frail People during Hospitalisation: A Pilot Study in Italy.Vaccines. 2023, 11 (12):
Justice Moses K Aheto, Iyanuloluwa Deborah Olowe, Ho Man Theophilus Chan, Adachi Ekeh, Boubacar Dieng, Biyi Fafunmi, Hamidreza Setayesh, Brian Atuhaire, Jessica Crawford, Andrew J Tatem, Chigozie Edson Utazi. Geospatial Analyses of Recent Household Surveys to Assess Changes in the Distribution of Zero-Dose Children and Their Associated Factors before and during the COVID-19 Pandemic in Nigeria.Vaccines. 2023, 11 (12):
Alexander Ciurej, Elizabeth Lewis, Avanti Gupte, Eman Al-Antary. Checkpoint Immunotherapy in Pediatric Oncology: Will We Say Checkmate Soon?Vaccines. 2023, 11 (12):